2YI1 - JenaLib

Asymmetric Unit (10, 14)

No.	Name	Count	Type	Full Name
1	2PE	1	Ligand/Ion	NONAETHYLENE GLYCOL
2	ACT	1	Ligand/Ion	ACETATE ION
3	ADP	1	Ligand/Ion	ADENOSINE-5'-DIPHOSPHATE
4	BM3	1	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-ALPHA-D-MANNOPYRANOSE
5	BMX	1	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-6-O-PHOSPHONO-ALPHA-D-MANNOPYRANOSE
6	CA	2	Ligand/Ion	CALCIUM ION
7	EDO	4	Ligand/Ion	1,2-ETHANEDIOL
8	MG	1	Ligand/Ion	MAGNESIUM ION
9	PG4	1	Ligand/Ion	TETRAETHYLENE GLYCOL
10	ZN	1	Ligand/Ion	ZINC ION

Biological Unit 1 (7, 20)

No.	Name	Count	Type	Full Name
1	2PE	2	Ligand/Ion	NONAETHYLENE GLYCOL
2	ACT	2	Ligand/Ion	ACETATE ION
3	ADP	2	Ligand/Ion	ADENOSINE-5'-DIPHOSPHATE
4	BM3	2	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-ALPHA-D-MANNOPYRANOSE
5	BMX	2	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-6-O-PHOSPHONO-ALPHA-D-MANNOPYRANOSE
6	CA	-1	Ligand/Ion	CALCIUM ION
7	EDO	8	Ligand/Ion	1,2-ETHANEDIOL
8	MG	-1	Ligand/Ion	MAGNESIUM ION
9	PG4	2	Ligand/Ion	TETRAETHYLENE GLYCOL
10	ZN	-1	Ligand/Ion	ZINC ION

Sites (14, 14)

Asymmetric Unit (14, 14)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	GLY A:415 , GLY A:416 , GLY A:475 , GLY A:476 , ARG A:477 , SER A:488 , THR A:489 , LEU A:491 , ASN A:516 , ASP A:517 , GLY A:543 , THR A:544 , GLY A:545 , ILE A:546 , GLY A:547 , GLU A:566 , HIS A:569 , GLU A:588 , ADP A:1727 , HOH A:2066 , HOH A:2087 , HOH A:2141	BINDING SITE FOR RESIDUE BMX A1000
02	AC2	SOFTWARE	GLY A:475 , GLY A:476 , ARG A:477 , SER A:488 , THR A:489 , LEU A:491 , ASN A:516 , ASP A:517 , ILE A:546 , GLY A:547 , GLU A:566 , HIS A:569 , GLU A:588 , HOH A:2066 , HOH A:2141	BINDING SITE FOR RESIDUE BM3 A1001
03	AC3	SOFTWARE	ASP A:413 , ADP A:1727 , HOH A:2002 , HOH A:2004 , HOH A:2142	BINDING SITE FOR RESIDUE MG A1717
04	AC4	SOFTWARE	GLN A:493 , VAL A:702	BINDING SITE FOR RESIDUE CA A1718
05	AC5	SOFTWARE	ASN A:516 , ASN A:519 , GLY A:548 , ALA A:564 , ALA A:565 , HOH A:2046 , HOH A:2066	BINDING SITE FOR RESIDUE CA A1719
06	AC6	SOFTWARE	VAL A:431 , LYS A:432 , LYS A:433 , TYR A:442 , GLU A:459 , GLU A:494 , ASN A:496 , VAL A:498 , HOH A:2016	BINDING SITE FOR RESIDUE 2PE A1720
07	AC7	SOFTWARE	GLY A:416 , ASN A:438 , LYS A:440 , ASP A:700 , HOH A:2026 , HOH A:2029 , HOH A:2030 , HOH A:2056	BINDING SITE FOR RESIDUE PG4 A1721
08	AC8	SOFTWARE	GLN A:451	BINDING SITE FOR RESIDUE EDO A1722
09	AC9	SOFTWARE	ARG A:481 , GLY A:559	BINDING SITE FOR RESIDUE EDO A1723
10	BC1	SOFTWARE	GLN A:692 , ASP A:693 , VAL A:694 , ASP A:695	BINDING SITE FOR RESIDUE EDO A1724
11	BC2	SOFTWARE	ASN A:418 , THR A:435	BINDING SITE FOR RESIDUE EDO A1725
12	BC3	SOFTWARE	HIS A:552 , HIS A:558 , GLY A:559 , HOH A:2094	BINDING SITE FOR RESIDUE ACT A1726
13	BC4	SOFTWARE	GLY A:415 , GLY A:416 , THR A:417 , ASN A:418 , ARG A:420 , THR A:544 , GLY A:593 , LEU A:625 , VAL A:670 , BMX A:1000 , MG A:1717 , HOH A:2110 , HOH A:2143	BINDING SITE FOR RESIDUE ADP A1727
14	BC5	SOFTWARE	HIS A:569 , CYS A:579 , CYS A:581 , CYS A:586	BINDING SITE FOR RESIDUE ZN A2000

SS Bonds (0, 0)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (16, 16)

Asymmetric Unit (16, 16)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_017955	A	460	V	GLCNE_HUMAN	Disease (NM)	121908631	A	A	460	V
02	UniProt	VAR_021781	I	472	T	GLCNE_HUMAN	Disease (NM)	---	A	I	472	T
03	UniProt	VAR_021782	N	519	S	GLCNE_HUMAN	Disease (NM)	---	A	N	519	S
04	UniProt	VAR_017956	A	524	V	GLCNE_HUMAN	Disease (NM)	764698870	A	A	524	V
05	UniProt	VAR_017957	F	528	C	GLCNE_HUMAN	Disease (NM)	---	A	F	528	C
06	UniProt	VAR_017958	I	557	T	GLCNE_HUMAN	Disease (NM)	---	A	I	557	T
07	UniProt	VAR_017959	V	572	L	GLCNE_HUMAN	Disease (NM)	121908632	A	V	572	L
08	UniProt	VAR_017960	G	576	E	GLCNE_HUMAN	Disease (NM)	121908625	A	G	576	E
09	UniProt	VAR_017961	I	587	T	GLCNE_HUMAN	Disease (NM)	748949603	A	I	587	T
10	UniProt	VAR_021783	A	600	T	GLCNE_HUMAN	Disease (NM)	387906347	A	A	600	T
11	UniProt	VAR_021784	A	630	T	GLCNE_HUMAN	Disease (NM)	---	A	A	630	T
12	UniProt	VAR_017962	A	631	T	GLCNE_HUMAN	Disease (NM)	121908626	A	A	631	T
13	UniProt	VAR_017963	A	631	V	GLCNE_HUMAN	Disease (NM)	62541771	A	A	631	V
14	UniProt	VAR_017964	Y	675	H	GLCNE_HUMAN	Disease (NM)	---	A	Y	675	H
15	UniProt	VAR_017965	V	696	M	GLCNE_HUMAN	Disease (NM)	121908627	A	V	696	M
16	UniProt	VAR_017966	M	712	T	GLCNE_HUMAN	Disease (NM)	28937594	A	M	712	T

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (16, 32)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_017955	A	460	V	GLCNE_HUMAN	Disease (NM)	121908631	A	A	460	V
02	UniProt	VAR_021781	I	472	T	GLCNE_HUMAN	Disease (NM)	---	A	I	472	T
03	UniProt	VAR_021782	N	519	S	GLCNE_HUMAN	Disease (NM)	---	A	N	519	S
04	UniProt	VAR_017956	A	524	V	GLCNE_HUMAN	Disease (NM)	764698870	A	A	524	V
05	UniProt	VAR_017957	F	528	C	GLCNE_HUMAN	Disease (NM)	---	A	F	528	C
06	UniProt	VAR_017958	I	557	T	GLCNE_HUMAN	Disease (NM)	---	A	I	557	T
07	UniProt	VAR_017959	V	572	L	GLCNE_HUMAN	Disease (NM)	121908632	A	V	572	L
08	UniProt	VAR_017960	G	576	E	GLCNE_HUMAN	Disease (NM)	121908625	A	G	576	E
09	UniProt	VAR_017961	I	587	T	GLCNE_HUMAN	Disease (NM)	748949603	A	I	587	T
10	UniProt	VAR_021783	A	600	T	GLCNE_HUMAN	Disease (NM)	387906347	A	A	600	T
11	UniProt	VAR_021784	A	630	T	GLCNE_HUMAN	Disease (NM)	---	A	A	630	T
12	UniProt	VAR_017962	A	631	T	GLCNE_HUMAN	Disease (NM)	121908626	A	A	631	T
13	UniProt	VAR_017963	A	631	V	GLCNE_HUMAN	Disease (NM)	62541771	A	A	631	V
14	UniProt	VAR_017964	Y	675	H	GLCNE_HUMAN	Disease (NM)	---	A	Y	675	H
15	UniProt	VAR_017965	V	696	M	GLCNE_HUMAN	Disease (NM)	121908627	A	V	696	M
16	UniProt	VAR_017966	M	712	T	GLCNE_HUMAN	Disease (NM)	28937594	A	M	712	T

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (0, 0)

Exons (0, 0)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:308
 aligned with GLCNE_HUMAN | Q9Y223 from UniProtKB/Swiss-Prot  Length:722

    Alignment length:313
                                   414       424       434       444       454       464       474       484       494       504       514       524       534       544       554       564       574       584       594       604       614       624       634       644       654       664       674       684       694       704       714   
          GLCNE_HUMAN   405 ETLSALAVDLGGTNLRVAIVSMKGEIVKKYTQFNPKTYEERINLILQMCVEAAAEAVKLNCRILGVGISTGGRVNPREGIVLHSTKLIQEWNSVDLRTPLSDTLHLPVWVDNDGNCAALAERKFGQGKGLENFVTLITGTGIGGGIIHQHELIHGSSFCAAELGHLVVSLDGPDCSCGSHGCIEAYASGMALQREAKKLHDEDLLLVEGMSVPKDEAVGALHLIQAAKLGNAKAQSILRTAGTALGLGVVNILHTMNPSLVILSGVLASHYIHIVKDVIRQQALSSVQDVDVVVSDLVDPALLGAASMVLDYT 717
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeeeeee...eeeeeeee....eeeeeeee...hhhhhhhhhhhhhhhhhhhhhhh..eeeeeeeee..eee....eeee..........eehhhhhhhhhh..eeeeehhhhhhhhhhhh........eeeeee...eeeeeee..ee.........hhhhh...............hhhhhhhhhhhhhhhhhhhhh.........-----..hhhhhhhhhhh.hhhhhhhhhhhhhhhhhhhhhhhhhhh..eeeee..hhhhhhhhhhhhhhhhhhhhhh..eeee....hhhhhhhhhhhhhhh Sec.struct. author
             SAPs(SNPs) (1) -------------------------------------------------------V-----------T----------------------------------------------S----V---C----------------------------T--------------L---E----------T------------T-----------------------------TT-------------------------------------------H--------------------M---------------T----- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------V-------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 2yi1 A 405 GTLSALAVDLGGTNLRVAIVSMKGEIVKKYTQFNPKTYEERINLILQMCVEAAAEAVKLNCRILGVGISTGGRVNPREGIVLHSTKLIQEWNSVDLRTPLSDTLHLPVWVDNDGNCAALAERKFGQGKGLENFVTLITGTGIGGGIIHQHELIHGSSFCAAELGHLVVSLDGPDCSCGSHGCIEAYASGMALQREAKKLHDEDLLLVEGMS-----AVGALHLIQAAKLGNAKAQSILRTAGTALGLGVVNILHTMNPSLVILSGVLASHYIHIVKDVIRQQALSSVQDVDVVVSDLVDPALLGAASMVLDYT 717
                                   414       424       434       444       454       464       474       484       494       504       514       524       534       544       554       564       574       584       594       604       614|     |624       634       644       654       664       674       684       694       704       714   
                                                                                                                                                                                                                                            615   621

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (20, 20)

Asymmetric Unit(hide GO term definitions)

Chain A (GLCNE_HUMAN | Q9Y223)

molecular function
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0009384	N-acylmannosamine kinase activity	Catalysis of the reaction: ATP + N-acyl-D-mannosamine = ADP + N-acyl-D-mannosamine 6-phosphate.
	GO:0008761	UDP-N-acetylglucosamine 2-epimerase activity	Catalysis of the reaction: UDP-N-acetyl-D-glucosamine = UDP-N-acetyl-D-mannosamine.
	GO:0003824	catalytic activity	Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	Catalysis of the hydrolysis of any O-glycosyl bond.
	GO:0016301	kinase activity	Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
biological process
	GO:0006045	N-acetylglucosamine biosynthetic process	The chemical reactions and pathways resulting in the formation of N-acetylglucosamine. The D isomer is a common structural unit of glycoproteins in plants, bacteria and animals; it is often the terminal sugar of an oligosaccharide group of a glycoprotein.
	GO:0006054	N-acetylneuraminate metabolic process	The chemical reactions and pathways involving N-acetylneuraminate, the anion of 5-(acetylamino)-3,5-dideoxy-D-glycero-D-galacto-non-3-ulosonic acid.
	GO:0006047	UDP-N-acetylglucosamine metabolic process	The chemical reactions and pathways involving UDP-N-acetylglucosamine, a substance composed of N-acetylglucosamine, a common structural unit of oligosaccharides, in glycosidic linkage with uridine diphosphate.
	GO:0046835	carbohydrate phosphorylation	The process of introducing a phosphate group into a carbohydrate, any organic compound based on the general formula Cx(H2O)y.
	GO:0007155	cell adhesion	The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
	GO:0016310	phosphorylation	The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

Visualization

Interactive Views

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		2PE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ACT	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ADP	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		BM3	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		BMX	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		CA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		EDO	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		PG4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ZN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2yi1)

Biological Unit
	Complete Structure
		Biological Unit 1	[ Jena3D ]

Still Images

Databases and Analysis Tools

Databases

Access by PDB/NDB ID
	2yi1
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	GLCNE_HUMAN \| Q9Y223
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	2.7.1.60
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	605820
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (10, 14)